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Editorial 
 
A mitochondrial view of cell fate 
 
The progressive transition of cell fate identity towards more differentiated states is a 
defining feature of organismal development. Recent breakthrough studies on cellular 
reprogramming demonstrated that this unidirectional process can be manipulated and 
reverted. Therefore, cell fate identity is plastic and can be modulated and fine-tuned to allow 
the generation of specified cell types. 
The mechanisms controlling this plasticity and cell fate specification are traditionally 
assumed to be almost entirely dependent on genetic/epigenetic regulation. However, this 
nuclear-centric view of cell fate identity might not be sufficiently exhaustive. Recently, 
mitochondria and energy metabolism have been shown to exert a critical role in governing 
stem cell reprogramming and differentiation. Metabolic intermediates may in fact function as 
epigenetic regulators. It is thus plausible that energetic requirement, redox homeostasis, and 
biosynthetic pathways, all of which are tightly linked to mitochondrial metabolism, may 
crosstalk with the nucleus to shape cellular identity.  
In this special issue, entitled “Mitochondria and metabolism remodeling in cellular 
reprogramming and differentiation”, we present seven review pieces by some of the key 
contributors of this nascent field summarizing the recent discoveries and upcoming challenges 
of the mitochondria/metabolic modulation in stem cell biology and in human disease states. 
 
The first review by Folmes and Terzic [1] functions as a perfect introduction to the 
field. It provides a comprehensive and detailed overview of the implications of energy 
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metabolism and mitochondria for stemness, reprogramming, and differentiation, and how 
these would reflect into regenerative medicine practice. 
The second manuscript by the group of Michael Teitell [2] focuses on the distinct 
features of stem cell mitochondria in the regulation of apoptosis. Deciphering these 
mechanisms would not only advance our understanding of the stem cell fate but may also help 
developing safer approaches for stem cell-based cellular replacement therapies. 
The review by Ruohola-Baker and colleagues [3] describes the metabolic changes 
observed in naïve-to-primed embryonic stem cell development and in cardiomyocyte 
maturation. Importantly, the authors suggest that dissecting the metabolic switches taking 
place in physiological development may shed light on potential strategies for correcting them 
in pathological cases. 
The piece written by Justin St. John [4] illustrates the relevance of mitochondrial 
genome, and its cross-talk with the chromosomal genome, during development and cellular 
reprogramming. In addition, it indicates how mitochondrial DNA may not only influence 
physiological differentiation but also the occurrence of human pathologies including cancer. 
In the review written by my team [5], we address the impact of mitochondrial and 
metabolic modulation on neural differentiation. Human brain energy metabolism exhibits 
unique features and the difficulty in reproducing them with the current model systems may be 
at the bases of the lack of therapeutic strategies. It is thus our hope that a new era of human 
stem cell-based models may bring novel opportunities for untreatable brain diseases. 
The article from the group of Ng Shyh-Chang [6] further explores the role of stem cell 
mitochondria during aging and age-associated diseases. The authors illustrate how stem cell 
factors and signaling pathways may converge on the mitochondria to modulate cellular and 
organismal longevity. Therefore, they conclude that targeting and repairing stem cell 
mitochondria might represent a strategy to counteract aging-related degenerative diseases in 
the future.   
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The current mitochondria-based therapeutic applications using mesenchymal stem 
cells are finally summarized in the manuscript by Yau-Huei Wei and colleagues [7]. The 
authors elucidate how the beneficial effect of mesenchymal stem cell transplantation may also 
be due to the transferring of stem cell mitochondria into the injured cells, thereby modulating 
cellular metabolism in situ. This may be relevant for improving the therapeutic outcomes of 
stem cell therapy in the future. 
 
In conclusion, mitochondria and energy metabolism appear as key regulators of cell 
fate identity and plasticity. Every step towards the understanding of their underlying 
mechanisms may not only advance our appreciation of stemness, reprogramming, and 
differentiation, but may also bring novel important knowledge concerning human diseases 
and targeted therapeutic strategies. Exciting discoveries are in front of us. 
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